Employees: 5,393
Size Pony Testing (300887.SZ) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $513M, the 3807th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥6.27 on 6 Nov 2026.
Performance Over six months the shares fell 35.0%, against -1.8% for the median peer and -16.4% for the China market (cap-weighted) — 2nd lowest of 21 in its peer set.
Growth Revenue fell 1.8% over the last twelve months (peer median +7.8%); the operating margin is -12.5% (peer median 12.7%).
Valuation It trades at 31.4× forward earnings against a peer median of 13.7× (most expensive of 15).
Capital Return on invested capital runs 9.2 points below its cost of capital (9.2% WACC).
Next results Next results expected around 27 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.33B | CN¥1.36B | CN¥1.54B | CN¥2.46B | CN¥3.76B |
| Revenue growth | — | -11% | -38% | -34% | — |
| Gross profit | CN¥575M | CN¥402M | CN¥410M | CN¥1.00B | CN¥1.28B |
| EBITDA | n/a | -CN¥6.42M | -CN¥139M | CN¥430M | CN¥590M |
| Net income | -CN¥175M | -CN¥246M | -CN¥356M | CN¥108M | CN¥323M |
| Free cash flow | CN¥54.0M | CN¥13.6M | -CN¥125M | -CN¥213M | CN¥140M |
| Capital expenditure | CN¥78.0M | CN¥106M | CN¥176M | CN¥557M | CN¥492M |
| Total debt | CN¥180M | CN¥141M | CN¥249M | CN¥292M | CN¥237M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300887.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -9.1% | -1.6% | 5th lowest of 21 |
| 6-month return | -35.0% | -1.8% | 2nd lowest of 21 |
| Distance from 52-week high | -62.7% | -18.9% | lowest of 21 |
| Revenue growth (TTM) | -1.8% | +7.8% | 5th lowest of 21 |
| Operating margin | -12.5% | 12.7% | 3rd lowest of 21 |
| Forward P/E | 31.4× | 13.7× | most expensive of 15 |
| ROIC minus cost of capital | -9.2 pp | +2.8 pp | 3rd lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Pony Testing 300887.SZ | China | $513M | -35% | -2% | -12% | 31.4× | n/a | n/a |
| Western Regions Tourism Development 300859.SZ | China | $513M | -30% | -13% | 15% | 25.4× | 38.8% | +44.7% |
| adesso ADN1.DE | Germany | $513M | +31% | +13% | 4% | 16.8× | 2.1% | +22.9% |
| Prestige International 4290.T | Japan | $518M | -4% | +10% | 13% | 13.4× | -12.4% | +11.8% |
| Diversified Royalty DIV.TO | Canada | $507M | -6% | +15% | 86% | 17.7× | 13.0% | +18.3% |
| Italian Exhibition IEG.MI | Italy | $505M | +14% | +4% | 18% | 13.2× | -4.8% | +28.4% |
| MHA MHA.L | United Kingdom | $504M | -4% | +12% | 15% | 11.7× | -15.0% | +30.6% |
| Shanghai Model Organisms Center 688265.SS | China | $503M | +7% | +14% | -1% | n/a | n/a | n/a |
| Ocumension Therapeutics 1477.HK | Hong Kong | $525M | -29% | +78% | -13% | n/a | n/a | n/a |
| BTS BTS-B.ST | Sweden | $527M | +76% | -4% | 8% | 25.6× | 10.7% | +13.0% |
| Nippon Parking Development 2353.T | Japan | $527M | +8% | +11% | 21% | 13.8× | -7.8% | +11.3% |
| Hunan Airbluer Environmental Protection Technology 301259.SZ | China | $498M | -47% | -43% | -17% | n/a | n/a | n/a |
| Posti POSTI.HE | Finland | $529M | +31% | 0% | 5% | 13.2× | -5.4% | -1.4% |
| Academy of Environmental Planning & Design Co., Ltd. Nanjing University 300864.SZ | China | $531M | 0% | +5% | 18% | n/a | 9.3% | +10.6% |
| Sporton International 6146.TWO | Taiwan | $531M | -24% | +8% | 30% | 13.6× | -6.6% | +5.0% |
| Guangdong Brandmax Marketing 300805.SZ | China | $533M | -19% | +13% | 1% | n/a | n/a | n/a |
| Restore RST.L | United Kingdom | $534M | +14% | +8% | 13% | 11.3× | 5.5% | +10.8% |
| Weathernews 4825.T | Japan | $534M | -11% | +5% | 21% | 19.7× | 3.4% | +5.4% |
| Mitsubishi Research Institute 3636.T | Japan | $489M | +8% | +4% | 7% | 11.2× | -9.9% | +4.1% |
| TKP 3479.T | Japan | $538M | +18% | +51% | 9% | 15.7× | -3.3% | +21.5% |
| Jianerkang Medical 603205.SS | China | $487M | -19% | -2% | 14% | n/a | -2.9% | -8.8% |